Latest strategies and progress: On diagnosis and treatment of asymptomatic hyperuricemia in the elderly
10.3760/cma.j.issn.0254-9026.2020.02.025
- VernacularTitle:老年人无症状高尿酸血症诊治策略及进展
- Author:
Ruihua ZHANG
1
;
Mingzhao QIN
Author Information
1. 首都医科大学附属北京同仁医院老年科 100730
- From:
Chinese Journal of Geriatrics
2020;39(2):233-237
- CountryChina
- Language:Chinese
-
Abstract:
The prevalence of hyperuricemia in elderly population aged over 60 years in China ranges from 5.5%-19.3%.With the population ageing, the number of the patients with hyperuricemia can be expected to grow.Whether elderly patients with asymptomatic hyperuricemia need active uric acid-lowering therapy is still a debatable entity because of lacking relevant clinical guidelines.In this paper, the metabolic process of uric acid, pathophysiologic mechanism of hyperuricemia, the treatment principle of hyperuricemia in combination with different comorbidities, and specific therapeutic schedules for asymptomatic hyperuricemia as well as drug therapy progress were reviewed as follows.
